Comorbidities of atopic dermatitis—what does the evidence say?
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 467 KB, PDF-dokument
Atopic dermatitis (AD) is a common disease that is associated with atopic and nonatopic comorbidities. There has been a growing interest in this area of AD, because presence or risk of comorbidities can in many ways impact the management of patients with AD. Thus, some treatments for AD may improve its comorbidities as well, whereas others may increase their risk. In this review article, we discuss various comorbidities of AD mostly on the basis of the results of recent multiple systematic reviews and meta-analyses to update readers about this rapidly developing area of dermatology. We emphasize the important information provided by studies presenting both relative risk and absolute risk, and show that AD is associated with, among others, atopic comorbidities such as asthma, rhinitis, and food allergy, nonatopic comorbidities such as ocular, psychiatric, infectious, endocrine, autoimmune, and cardiovascular diseases, and certain cancers. Clinicians need to be aware of these and be cognizant about positive and negative effects of existing and new treatments for AD.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Allergy and Clinical Immunology |
Vol/bind | 151 |
Udgave nummer | 5 |
Sider (fra-til) | 1155-1162 |
ISSN | 0091-6749 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
J.P.T. is supported by an unrestricted grant from the Lundbeck Foundation.
Publisher Copyright:
© 2022 The Authors
ID: 334263879